The 20 Best Splenectomy Doctors in Texas, US

Rosemary Kozar is an Intensive Care Medicine provider practicing medicine in Houston, Texas. Dr. Kozar is rated as a Distinguished provider by MediFind in Splenectomy. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Delirium, Chronic Subdural Hematoma, Subdural Hematoma, Splenectomy, and Colostomy.

Jessica Ngo is a primary care provider, practicing in Internal Medicine in Dallas, Texas. Dr. Ngo is rated as an Experienced provider by MediFind in Splenectomy. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses High Cholesterol, Vitamin D Deficiency, Cirrhosis, Familial Combined Hyperlipidemia, and Splenectomy.

Dr. William E. Fisher is Professor and Vice-Chair for Clinical Affairs, Department of Surgery and the George L. Jordan, M.D. Chair in General Surgery at Baylor College of Medicine. Dr. Fisher also serves as Director of the Elkins Pancreas Center at BCM; and is Vice President, Medical Staff and Chief of the Surgery Service Line at Baylor St. Luke’s Medical Center.An internationally-known leader in pancreatic surgery, Dr. Fisher has focused entirely on surgery for pancreatic tumors and cysts in his practice for over 20 years and has extensive experience in advanced, minimally-invasive robotic pancreas surgery.Dr. Fisher’s professional interests include: pancreaticoduodenectomy (Whipple procedure); minimally invasive/laparoscopic/robotic pancreatic surgery; pancreas cancer; distal and central pancreatectomy; pancreas resection; surgical oncology; common bile duct resection; Puestow procedure; Frey procedure; and laparoscopic pancreatectomy.Dr. Fisher has served as PI of two NIH-funded multicenter randomized clinical trials that generated practice-changing impact on the use of drains during pancreatectomy, and the subsequent development of a multicenter pancreatic-surgery-outcomes consortium. His basic science lab has studied the influence of gastrointestinal hormones on pancreatic cancer growth, the relationship between diabetes and pancreatic cancer, and genomic analysis of pancreatic cancer, resulting in over 160 peer-reviewed publications.Having served as principal investigator on more than 15 clinical trials for patients with pancreatic cancer, Dr. Fisher is currently PI at BCM for the NIH Consortium to Study Chronic Pancreatitis, Diabetes and Pancreatic Cancer.Dr. Fisher received a B.A. from Wittenberg University and earned his medical degree from the University of Cincinnati College of Medicine.  He held a research fellowship and completed his residency at The Ohio State University.Among his numerous honors and awards, Dr. Fisher has been recognized as one of America’s Top Doctors for Cancer (Castle Connolly Medical Ltd.), Top 1% of Doctors in the U.S. (U.S. News and World Report), and “Texas Super Doctor” (Texas Monthly). He is also the recipient of the Master Clinician Award for Excellence in Patient Care from BCM and has twice received the DeBakey Distinguished Service Award from the Michael E. DeBakey Department of Surgery at BCM. Dr. Fisher is rated as an Advanced provider by MediFind in Splenectomy. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Chronic Pancreatitis, Pancreatic Cancer, Hereditary Pancreatitis, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Fisher is currently accepting new patients.

Suhail Sharif is a General Surgeon practicing medicine in Fort Worth, Texas. Dr. Sharif is rated as an Advanced provider by MediFind in Splenectomy. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Familial Pancreatic Cancer, Pancreatic Cancer, Familial Colorectal Cancer, Splenectomy, and Pancreatectomy. Dr. Sharif is board certified in General Surgery- American Board Of Surgery/General Surgery and General Surgery- American Board Of Surgery.

George Van Buren, II, M.D. is an associate professor of surgery in the Division of Surgical Oncology of the Michael E. DeBakey Department of Surgery at Baylor College of Medicine. Dr. Van Buren is a board-certified surgeon specializing surgical oncology and pancreatic disorders.A native Houstonian, Dr. Van Buren earned his undergraduate degree at the University of Texas at Austin and his medical degree at the University of Texas Medical School at Houston. He completed his general surgery residency at the University of Texas Medical School at Houston. During that time period, he spent two years at MD Anderson Cancer Center as an NIH T32 research fellow studying pancreatic cancer and neuroendocrine tumors. He completed his surgical oncology fellowship at the University of Pittsburgh Medical Center in the Translational Pancreas Research Track.During Dr. Van Buren’s research and clinical fellowships, he was able to expand upon his interest in gastrointestinal surgical oncology and pancreatic disorders. Specifically, his training had a heavy emphasis on pancreatic and gastric malignancies with exposure to wide breadth of cases, including specialized procedures such as robotic pancreatic surgery.Dr. Van Buren is active in both patient care and research. He has spent over 15 years in training and in practice focusing on care for patients with pancreatic and gastrointestinal malignancies. He is involved in both basic science and clinical research and believes heavily in the surgeon’s role as a leader of the translational research team. His goals are to provide high quality clinical care while offering his patients access to innovative clinical and therapeutic trials. He is a member of the Elkins Pancreas Center and Dan L. Duncan NCI Cancer Center at Baylor College of Medicine. Dr. Van Buren is rated as an Advanced provider by MediFind in Splenectomy. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Gallbladder Cancer, Gallbladder Adenocarcinoma, Splenectomy, and Pancreatectomy. Dr. Van Buren is currently accepting new patients.

Dr. Tom Shires is a Fellow of the American College of Surgeons and sits on their Board of Governors. He specializes in hepatic, pancreatic and biliary surgery. He has followed in the footsteps of his surgeon father, who was a leading researcher and pioneer in the areas of trauma and burn care. Dr. Shires currently serves as the John P. Thompson Chair for Surgical Services at Texas Health Presbyterian Hospital Dallas and on the hospital's Board of Trustees. He also sits on numerous committees, including Texas Health Dallas' Medical Executive Committee and Surgical Services Committee.Dr. Shires graduated with honors from Duke University School of Medicine in Durham, N.C., and completed his general surgery residency training at Emory University School of Medicine in Atlanta, Ga. He was the Harvey Cushing Research Fellow at Cornell University Medical College New York Presbyterian Hospital and the Daniel Elkin Clinical Fellow at Emory.He has decades of experience in the use of advanced and minimally invasive surgical techniques. He previously served as Chief of Surgery at Zale-Lipshy University Hospital in Dallas and as Chairman of the GI and Endocrine Division at The University of Texas Southwestern Medical Center, also in Dallas. Dr. Shires is an avid lecturer, author, medical editor and medical reviewer. Dr. Shires' special interest in surgical education shows through in his role as the residency program director for surgery residents at Texas Health Dallas.Dr. Shires is an active member of such organizations as the North Texas Chapter of the American College of Surgeons, American Hepato Pancreato Biliary Association, The Society for Surgery of the Alimentary Tract, Surgical Infection Society and Association for Academic Surgery. Dr. Shires is rated as an Advanced provider by MediFind in Splenectomy. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Esophageal Cancer, Pancreatectomy, and Hernia Surgery.

David Smith is a Surgical Oncologist practicing medicine in Tyler, Texas. Dr. Smith is rated as an Advanced provider by MediFind in Splenectomy. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Congenital Diaphragmatic Hernia, Small Bowel Resection, and Pancreatectomy. Dr. Smith is board certified in American Board Of Surgery.

Lillian Kao is an Intensive Care Medicine provider practicing medicine in Houston, Texas. Dr. Kao is rated as an Advanced provider by MediFind in Splenectomy. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Hernia, Appendicitis, Gallstones, Appendectomy, and Gallbladder Removal.

Martin Zielinski, MD, is dedicated to delivering high-quality, compassionate care to Houston and nearby communities. Martin Zielinski specializes in Surgery: Critical Care and works at BCM General Surgery. To make an appointment, please call (713) 798-7911. To review all accepted insurance carriers, please visit: https://www.stlukeshealth.org/patients-visitors/patients/billing-insurance/insurances-accepted. Dr. Zielinski is rated as an Advanced provider by MediFind in Splenectomy. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Appendicitis, Post-Splenectomy Syndrome, Choledocholithiasis, Appendectomy, and Small Bowel Resection. Dr. Zielinski is currently accepting new patients.

Dr. Omar Barakat is a general surgeon specializing in benign and malignant diseases of the liver, bile duct, gallbladder, and pancreas. He is an Associate Professor of Surgery - Division of Surgical Oncology at Baylor College of Medicine and Medical Director of the Neuroendocrine Tumor Program at Baylor St. Luke’s Medical Center.Dr. Barakat’s clinical interests include: malignant hepatobiliary and pancreatic diseases, liver and pancreas surgery; upper gastrointestinal surgery; neuroendocrine tumors; gastrointestinal stromal tumors (GIST); and minimally invasive surgery.Dr. Barakat has developed new surgical techniques to minimize the complication rate and blood loss following pancreatic and liver surgeries. He utilizes image-guided therapies, such as radiofrequency ablation, microwave ablation, irreversible electroporation (NanoKnife system), trans-arterial chemotherapy, and selective internal radiotherapy (SIRT) with Yttrium-90 microspheres, to treat liver tumors while minimizing trauma to the patients. Dr. Barakat's clinical and research interests also include the study of neuroendocrine tumors; and the development of off-the-shelf bio-artificial liver organs that can be suitable for liver transplantation in patients with end-stage liver disease.Dr. Barakat received his medical degree from Aleppo University Medical School in Aleppo, Syria. He completed a residency in general surgery at the Medical College of Pennsylvania, Episcopal Hospital in Philadelphia and a Fellowship in cardiovascular surgery research at State University of New York - Buffalo. He also completed clinical fellowships in liver transplantation at The University of Texas Health Science Center in Houston; and in heart transplantation and mechanical assist devices aat the Texas Heart Institute. He continued his practice in liver and pancreatic surgery at Freeman Hospital in Newcastle Upon-Tyne, United Kingdom, where he treated complex and rare tumors of the liver, bile duct, and pancreas. Dr. Barakat is board-certified by the Royal College of Surgeons (Ed), United Kingdom, where he is also a Fellow. Dr. Barakat is rated as an Experienced provider by MediFind in Splenectomy. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Bile Duct Stricture, Chronic Pancreatitis, Gallbladder Disease, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Barakat is currently accepting new patients.

Joseph Coselli is a Thoracic Surgeon practicing medicine in Houston, Texas. Dr. Coselli is rated as an Experienced provider by MediFind in Splenectomy. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Thoracic Aortic Aneurysm, Aortic Dissection, Marfan Syndrome, Coronary Artery Bypass Graft (CABG), and Aortic Valve Replacement. Dr. Coselli is currently accepting new patients.

Scott Celinski is a Surgical Oncologist and a General Surgeon practicing medicine in Dallas, Texas. Dr. Celinski is rated as an Experienced provider by MediFind in Splenectomy. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Pancreatectomy, and Pancreaticoduodenectomy. Dr. Celinski is board certified in General Surgery- American Board Of Surgery/General Surgery, Surgical Critical Care- American Board Of Surgery/Surgical Critical Care, General Surgery- American Board Of Surgery, and Surgical Critical Care- American Board Of Surgery.

Robert Goldstein, MD, FACS is a Clinical Professor at Texas A&M College of Medicine at Texas A&M Health Science Center, Dallas. He is Medical Director of the Liver and Pancreas Disease Center at the Annette C. and Harold C. Simmons Transplant Institute. He is also Chief of Hebatobilliary Surgery and Director of the General Surgery Residency Program at Baylor University Medical Center, part of Baylor Scott & White Health. Dr. Goldstein's clinical interests include liver cancer, bile duct cancer and bile duct injuries. He provides immediate evaluation and medical management of patients with newly diagnosed benign and cancerous liver lesions. He and a team of transplant and oncologic surgery specialists work together to offer aggressive advanced treatments. With 30 years of experience in a high-volume transplant center, Dr. Goldstein is one of the most practiced hepatobilliary surgeons in the nation. Dr. Goldstein received his medical degree from the University of Tennessee Health Science Center in Memphis. He completed his residency at West Virginia University School of Medicine. He went on to start a transplant fellowship at the University of Pittsburgh and completed the transplant fellowship at Baylor University Medical Center in Dallas where he has dedicated his entire medical career to the care and treatment of liver cancer patients and liver transplant patients. Read more about Dr. Goldstein's publications on PubMed.gov and the Baylor Health Sciences Library. Read more about Dr. Goldstein's publications. Dr. Goldstein has been named one of D Magazine’s Best Docs at least 15 times earning him a place on D Magazine’s Hall of Fame list. Dr. Goldstein has been named one of Texas Monthly's Texas Super Doctors for the past 15 years earning him a place on Texas Monthly's Legacy list. Dr. Goldstein is rated as an Experienced provider by MediFind in Splenectomy. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Fibrolamellar Carcinoma, Progressive Familial Intrahepatic Cholestasis Type 2, Progressive Familial Intrahepatic Cholestasis Type 1, Liver Transplant, and Splenectomy. Dr. Goldstein is board certified in Transplant Surgery- American Board Of Surgery/General Surgery, - American Board Of Surgery/General Surgery, General Surgery- American Board Of Surgery/General Surgery, Transplant Surgery- American Board Of Surgery, and General Surgery- American Board Of Surgery.

Bryan Parrent, MD, is a board-certified surgeon by the American Board of Surgery. Dr. Parrent is also a Fellow of the American College of Surgeons and the American Society of Metabolic and Bariatric Surgeons. He completed his Bachelor's in Biology with a minor in Chemistry at Texas A&M University in 1996, graduating Magna Cum Laude. In 2000, Dr. Parrent completed medical school at the Texas A&M Health Science Center in College Station, Texas, followed by his general surgery residency at Baylor University Medical Center in Dallas, Texas. As a general surgeon, Dr. Parent specializes in treatment using the Davinci Robot for minimally invasive procedures. Dr. Parrent was named one of Texas Monthly's Rising Stars from 2012 to 2014 and Super Doctors from 2015 to the present. Dr. Parrent is rated as an Experienced provider by MediFind in Splenectomy. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Hernia, Familial Colorectal Cancer, Paget Disease of the Breast, Ileostomy, and Hip Replacement. Dr. Parrent is currently accepting new patients.

Jeffrey Lamont is a General Surgeon and a Surgical Oncologist practicing medicine in Plano, Texas. Dr. Lamont is rated as an Experienced provider by MediFind in Splenectomy. He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Familial Pancreatic Cancer, Pancreatic Cancer, Pancreatectomy, and Small Bowel Resection. Dr. Lamont is board certified in General Surgery- American Board Of Surgery/General Surgery and General Surgery- American Board Of Surgery.

Shawn S. Groth, M.D. is a board-certified general thoracic surgeon in Houston who specializes in minimally invasive thoracic surgery. After finishing his cardiothoracic surgery residency under Dr. David J. Sugarbaker at the Brigham and Women’s Hospital, Harvard Medical School, Dr. Groth pursued an advanced fellowship in minimally invasive esophageal surgery at the University of Pittsburgh under the mentorship of Dr. James D. Luketich, a pioneer in minimally invasive foregut surgery. Dr. Groth seeks to bring that expertise to Baylor. As part of a team effort with other health care providers, Dr. Groth’s practice includes the multi-disciplinary management of benign and malignant disorders of the esophagus/foregut, lung, pleural space, mediastinum, chest wall, and diaphragm. As the Director of Esophageal Surgical Services at Baylor St. Luke’s Medical Center, Dr. Groth will co-direct a newly created swallow center, which will provide a multi-disciplinary approach to managing patients with gastroesophageal reflux disease and esophageal motility disorders. He provides minimally invasive approaches to managing benign (e.g., gastroesophageal reflux disease, paraesophageal hernias, achalasia, benign strictures, and esophageal diverticuli) and malignant foregut disorders (e.g., malignant strictures and esophageal and gastroesophageal junction cancers), as well as Barrett’s esophagus. Already a well-published investigator, Dr. Groth has presented his work at numerous national society meetings, including The American College of Surgeons, The American College of Chest Physicians, The American Society of Clinical Oncology, The Society of Thoracic Surgeons, and The American Association for Thoracic Surgery. Dr. Groth’s clinical research focuses on thoracic oncology outcomes research, health care disparities research, and clinical trials. He has explored several topics directed towards improving the guideline treatment of cancer patients. His basic science and translational research efforts are directed towards advancing personalized oncology. In light of the COVID-19 pandemic, the Baylor College of Medicine General Thoracic Surgery Clinic is offering telemedicine clinic visits. To schedule, please call the main line at 713-798-6376. Dr. Groth is rated as an Experienced provider by MediFind in Splenectomy. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Mesothelioma, Achalasia, Metastatic Pleural Tumor, Endoscopy, and Gastrostomy. Dr. Groth is currently accepting new patients.

Subhasis Chatterjee, M.D. is an assistant professor of surgery on the Surgical Critical Care team at Baylor St. Luke's Medical Center. Dr. Chatterjee was selected to the Medical Scholars Program at the University of Wisconsin, earning both his undergraduate and medical degrees in addition to being selected to the Alpha Omega Alpha honor society. He completed his general surgery training at the University of Pennsylvania and his cardiothoracic surgical training at New York Presbyterian Cornell & Memorial Sloan-Kettering Cancer Center. After being in private practice in Illinois and Wisconsin he completed a fellowship in critical care at the Mayo Clinic Rochester. His clinical focus is in the critical care of cardiothoracic surgical patients with a perspective as both a cardiothoracic surgeon and intensivist. He is dedicated to excellent patient outcomes and multidisciplinary collaboration. His basic science areas of investigation included an NIH-sponsored grant for gene therapy in ischemia-reperfusion injury after myocardial infarction. He has participated and served as an investigator in a number of clinical trials. His clinical focus in research is in mechanical circulatory support, resource utilization, and critical care scoring systems for the care of cardiothoracic surgical patients. Dr. Chatterjee is rated as an Experienced provider by MediFind in Splenectomy. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Cardiogenic Shock, Thoracic Aortic Aneurysm, Aortic Dissection, Coronary Artery Bypass Graft (CABG), and Heart Bypass Surgery. Dr. Chatterjee is board certified in American Board Of SurgeryAmerican Board Of Thoracic SurgeryCritical CareAmerican Board Of Surgery. Dr. Chatterjee is currently accepting new patients.

Justin Segraves, MD, is dedicated to delivering high-quality, compassionate care to Houston and nearby communities. Justin Segraves specializes in Pulmonary Disease and works at BCM - St. Luke's Medical Center - Lung Transplant Team. To make an appointment, please call (832) 355-2285. To review all accepted insurance carriers, please visit: https://www.stlukeshealth.org/patients-visitors/patients/billing-insurance/insurances-accepted. Dr. Segraves is rated as an Experienced provider by MediFind in Splenectomy. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Cerebral Hypoxia, Arteriovenous Malformation, Acute Interstitial Pneumonia, Lung Transplant, and Splenectomy. Dr. Segraves is currently accepting new patients.

Dr. Senthil Sukumar specializes in the care of adults with non-malignant hematologic disorders. He is an Assistant Professor of Medicine - Hematology and Oncology at Baylor College of Medicine. Dr. Sukumar’s clinical interests include: benign hematology; thrombotic microangiopathy; thrombotic thrombocytopenic purpura; atypical hemolytic uremic syndrome; thrombosis; thrombocytopenia; anemias; and bleeding and clotting disorders. His research interests include: optimizing long-term care and improving outcomes of patients with thrombotic microangiopathies. Dr. Sukumar received his medical degree from University of Missouri-Kansas City School of Medicine. He completed his residency at the University of Texas Southwestern Medical Center in Dallas and a fellowship at The Ohio State University James Comprehensive Cancer Center. He also received a Master of Science degree from The Ohio State University. Dr. Sukumar is board-certified in Hematology and Internal Medicine from American Board of Internal Medicine. He is a member of the American Society of Hematology, Hemostasis and Thrombosis Research Society, and the International Society on Thrombosis and Haemostasis. Dr. Sukumar is rated as an Experienced provider by MediFind in Splenectomy. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Thrombocytopenia, Ghosal Hematodiaphyseal Dysplasia, Blood Clots, Anemia, and Splenectomy. Dr. Sukumar is currently accepting new patients.

Dr. E. Ramsay Camp is Professor and Chief of the Division of Surgical Oncology in the Michael E. DeBakey Department of Surgery at Baylor College of Medicine.Dr. Camp’s clinical practice and expertise has focused on treating patients with complex tumors of the gastrointestinal system, including pancreatic and gastric malignancies, as well as sarcoma and melanoma. His professional interests include surgical oncology, pancreatic cancer, pancreaticobiliary malignancies, gastric cancer, sarcoma, melanoma, small bowel tumors, neuroendocrine tumors, gastrointestinal tumors, minimally invasive surgery, and hyperthermic intraperitoneal chemotherapy (HIPEC).Dr. Camp earned a B.A. in Chemistry from Davidson College and received his medical degree from the Medical University of South Carolina. He completed his general surgery training at Shand's Hospital at the University of Florida and finished a surgical oncology fellowship at the University of Texas M.D. Anderson Cancer Center.Following 12 years in practice at the Medical University of South Carolina, Dr. Camp joined the faculty of Baylor as the Chief of Surgical Oncology. He has an active, externally-funded research laboratory supported by a VA Merit Award, focusing on mechanisms of chemotherapy and radiation resistance in pancreatic and colorectal cancer.Dr. Camp is a fellow of the American College of Surgeons and a member of various oncology societies, including the American Surgical Association, the Southern Surgical Association, Society of Surgical Oncology, American Society of Clinical Oncology, American Association of Cancer Research, National Surgical Adjuvant Bowel Project, Southwest Oncology Group, and the American College of Surgeons Oncology Group.Professional Interests:Surgical oncologyPancreatic cancerPancreaticobiliary malignanciesGastric cancer and other gastric malignanciesSarcomaMelanomaSmall bowel tumorsNeuroendocrine tumorsGasrointestinal tumorsMinimally invasive surgeryHIPEC. Dr. Camp is rated as an Experienced provider by MediFind in Splenectomy. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Stomach Cancer, Melanoma, Familial Pancreatic Cancer, Pancreatectomy, and Small Bowel Resection. Dr. Camp is currently accepting new patients.